{"id":"W2948816951","doi":"10.1001/jamapsychiatry.2019.1189","title":"Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression","year":2019,"lang":"en","type":"article","venue":"JAMA Psychiatry","topic":"Treatment of Major Depression","field":"Medicine","cited_by":759,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Agency for Healthcare Research and Quality; Janssen Research and Development; Allergan; Gobierno de Navarra; Patient-Centered Outcomes Research Institute; H. Lundbeck A/S; Cerecor; Sunovion; AstraZeneca; Eli Lilly and Company; University of Oxford; Otsuka America; Cancer Prevention and Research Institute of Texas; National Institute of Mental Health; Pfizer","keywords":"Nasal spray; Medicine; Placebo; Antidepressant; Treatment-resistant depression; Randomized controlled trial; Internal medicine; Anesthesia; Depression (economics); Nasal administration; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001268234,0.0003312347,0.001352538,0.0002354331,0.0001961228,0.0003315209,0.0003449443,0.0004145587,0.001195266],"category_scores_gemma":[0.001961882,0.0002145925,0.0010232,0.0002125511,0.0002619454,0.0002893917,0.0001704325,0.0006791843,0.0001418071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002983118,"about_ca_system_score_gemma":0.0004271027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006146324,"about_ca_topic_score_gemma":0.002664577,"domain_scores_codex":[0.9993708,0.0003439813,0.00009634529,0.00005847221,0.00009653309,0.00003397146],"domain_scores_gemma":[0.9991411,0.0002856234,0.0003319134,0.00004640821,0.00005997953,0.0001348194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5264648,0.01736881,0.06463201,0.003262786,0.004460795,0.0002003879,0.0002463858,0.0005895316,0.01524491,0.0001179048,0.00126221,0.3661495],"study_design_scores_gemma":[0.3025857,0.3836267,0.3027036,0.0004425249,0.003135731,0.0004692917,0.0001844802,0.002381705,0.002424772,0.0001549339,0.00183882,0.0000518068],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931909,0.005470508,0.0001324323,0.0001454551,0.00005242214,0.000326541,0.0001008601,0.00001673984,0.0005641222],"genre_scores_gemma":[0.9961413,0.002514883,0.0005925447,0.0001792254,0.00007512895,0.0001969607,0.0001451885,0.000002117647,0.0001526136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001352538,"threshold_uncertainty_score":0.006707191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01235809832960181,"score_gpt":0.2816299973655121,"score_spread":0.2692718990359103,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}